HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Crystagen |
|---|---|
| Class | Longevity, cognitive & bioregulators |
| Molecular formula | C14H21N3O8 |
| Molecular weight | 359.33 g/mol |
| Sequence | Glu-Asp-Pro (EDP) |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 20mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture, for long-term stability; brief ambient exposure during shipping is tolerated. After reconstitution, keep refrigerated at 2-8°C and use within the validated period. Handle as a research material only. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Crystagen is a synthetic Khavinson short-peptide bioregulator with the sequence Glu-Asp-Pro (EDP), studied as an immune/thymic regulatory peptide and supplied for research use as a lyophilized powder.
Documentation
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Crystagen reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Crystagen is a synthetic short-peptide bioregulator corresponding to the sequence Glu-Asp-Pro (EDP), part of the Khavinson bioregulator family. Pepti supplies it as a research-use lyophilized powder in 20 mg vials for laboratory and private-label applications.
Each batch is accompanied by a Certificate of Analysis reporting HPLC purity (typically ≥98%), mass-spectrometry identity confirmation against the expected molecular weight (~359.3 g/mol), and appearance and water-content data. Safety data sheets and stability information are available on request.
The standard catalog format is 20 mg per vial with a minimum order quantity of 50 vials. Bulk peptide powder, alternative fill weights, and custom vialing are quoted separately via RFQ.
Yes. Pepti supports OEM and private-label programs, including custom labeling, kit and packaging configuration, and documentation aligned to your specifications. COA parameters and fill weights can be tailored to your requirements.
No public CAS registry number is assigned to Crystagen (Glu-Asp-Pro). Identity is instead confirmed per batch by HPLC and mass spectrometry against the expected molecular weight of approximately 359.3 g/mol, with full analytical data provided on the COA. Material is sold strictly for research use and is not for human or clinical use.
Related compounds